BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3626543)

  • 1. The effect of indomethacin on burn-induced immunosuppression.
    Latter DA; Tchervenkov JI; Nohr CW; Christou NV
    J Surg Res; 1987 Sep; 43(3):246-52. PubMed ID: 3626543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to bacterial sepsis. Accurate measurement by the delayed-type hypersensitivity skin test score.
    Tchervenkov JI; Diano E; Meakins JL; Christou NV
    Arch Surg; 1986 Jan; 121(1):37-40. PubMed ID: 3942498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered leukocyte delivery to specific and nonspecific inflammatory skin lesions following burn injury.
    Tchervenkov JI; Latter DA; Psychogios J; Christou NV
    J Trauma; 1988 May; 28(5):582-8. PubMed ID: 3259268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early burn wound excision and skin grafting postburn trauma restores in vivo neutrophil delivery to inflammatory lesions.
    Tchervenkov JI; Epstein MD; Silberstein EB; Alexander JW
    Arch Surg; 1988 Dec; 123(12):1477-81. PubMed ID: 3056334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the immunomodulator RU 41,740 (biostim) on the specific and nonspecific immunosuppression induced by thermal injury or protein deprivation.
    Christou NV; Zakaluzny I; Marshall JC; Nohr CW
    Arch Surg; 1988 Feb; 123(2):207-11. PubMed ID: 3124797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of albumin or crystalloid resuscitation on bacterial translocation and endotoxin absorption following experimental burn injury.
    O'Brien R; Murdoch J; Kuehn R; Marshall JC
    J Surg Res; 1992 Feb; 52(2):161-6. PubMed ID: 1740939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of long-term protein deprivation on in vivo phagocytic cell delivery to inflammatory lesions.
    Tchervenkov JI; Latter DA; Psychogios J; Christou NV
    Surgery; 1988 Apr; 103(4):463-9. PubMed ID: 3127909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclosporine on host defence.
    Tchervenkov JI; Diano E; Christou NV
    Can J Surg; 1985 Nov; 28(6):525-7. PubMed ID: 4063893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunomodulating effect of TP5 and indomethacin in burn-induced hypoimmunity.
    Maghsudi M; Miller CL
    J Surg Res; 1984 Aug; 37(2):133-8. PubMed ID: 6235402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of prostaglandin E2 in immune suppression following injury.
    Grbic JT; Mannick JA; Gough DB; Rodrick ML
    Ann Surg; 1991 Sep; 214(3):253-62; discussion 262-3. PubMed ID: 1929607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response: effects of operative stress in a pediatric model.
    Mendoza-Sagaon M; Gitzelmann CA; Herreman-Suquet K; Pegoli W; Talamini MA; Paidas CN
    J Pediatr Surg; 1998 Feb; 33(2):388-93. PubMed ID: 9498424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low dose recombinant interleukin 2 plus indomethacin on mortality after sepsis in a murine burn model.
    Horgan PG; Mannick JA; Dubravec DB; Rodrick ML
    Br J Surg; 1990 Apr; 77(4):401-4. PubMed ID: 2340389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of macrophage hyperactivity improves survival in a burn-sepsis model.
    O'Riordain MG; Collins KH; Pilz M; Saporoschetz IB; Mannick JA; Rodrick ML
    Arch Surg; 1992 Feb; 127(2):152-7; discussion 157-8. PubMed ID: 1540091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of serum opsonic defects after burn and sepsis by opsonic fibronectin administration.
    Lanser ME; Saba TM
    Arch Surg; 1983 Mar; 118(3):338-42. PubMed ID: 6824434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent changes of immunologic responses after burn injury and immunomodulation by cimetidine and pyrimethamine in an animal model.
    A J; Zm H; M E; S MH; T T
    Pak J Pharm Sci; 2010 Oct; 23(4):367-73. PubMed ID: 20884448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postburn immunosuppression in an animal model. II. Restoration of cell-mediated immunity by immunomodulating drugs.
    Hansbrough J; Peterson V; Zapata-Sirvent R; Claman HN
    Surgery; 1984 Mar; 95(3):290-6. PubMed ID: 6322373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin-mediated suppression of delayed-type hypersensitivity to infected erythrocytes during Babesia microti infection in mice.
    Ruebush MJ; Steel LK; Kennedy DA
    Cell Immunol; 1986 Apr; 98(2):300-10. PubMed ID: 2944617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine improves survival in burn injury followed by sepsis in rats.
    Gurfinkel R; Czeiger D; Douvdevani A; Shapira Y; Artru AA; Sufaro Y; Mazar J; Shaked G
    Anesth Analg; 2006 Aug; 103(2):396-402, table of contents. PubMed ID: 16861423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulators for the prevention of infections in burned guinea pigs.
    Waymack JP; Alexander JW
    J Burn Care Rehabil; 1987; 8(5):363-5. PubMed ID: 3667662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of vitamin D
    Liu XZ; You B; Zhang YL; Yang ZC; Chen P; Shi YL; Chen Y; Chen YJ; Chen J; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2019 Apr; 35(4):284-291. PubMed ID: 31060176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.